Adali-graph-01.jpg (Adali Graph 01)
Dosage regimen: 40 mg every other week. Treatment includes placebo.*
Idacio Kit
Product Images NDC 65219-558
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 21 technical images submitted to the FDA as part of the official labeling for Idacio (NDC 65219-558). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Adali-graph-02.jpg (Adali Graph 02)
Adali-graph-03.jpg (Adali Graph 03)
Adali-graph-04.jpg (Adali Graph 04)
Adali-img-01.jpg (Adali Img 01)
Adali-img-02.jpg (Adali Img 02)
Adali-img-03.jpg (Adali Img 03)
Adali-img-04.jpg (Adali Img 04)
Adali-img-05.jpg (Adali Img 05)
Adali-img-06.jpg (Adali Img 06)
Adali-img-07.jpg (Adali Img 07)
Adali-img-08.jpg (Adali Img 08)
Adali-img-09.jpg (Adali Img 09)
Adali-img-10.jpg (Adali Img 10)
Adali-img-11.jpg (Adali Img 11)
Adali-img-12.jpg (Adali Img 12)
Adali-img-13.jpg (Adali Img 13)
Adali-img-14.jpg (Adali Img 14)
Adali-img-15.jpg (Adali Img 15)
Label-pdpimage (Adali Label 01)
Adali-label-02.jpg (Adali Label 02)
This is a description of a single-dose vial containing IdOC|O 40mg/0.8mL NoCESZIS (adalimumab-aacf) injection for subcutaneous use only. It is indicated to discard any unused portion and provides information on expiry date, lot number, and the manufacturer, which is Fresenius Kabi USA, LLC.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
